Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessEarningsRanbaxy effect playing on Sun Pharma's margins: Pros

SHOW NAMES

Trending Topics

business

Ranbaxy effect playing on Sun Pharma's margins: Pros

Sarabjit Kour Nangra, VP- Research, Angel Broking, believes it to be the Ranbaxy effect. However, she says 14.5 percent is very low, because after consolidation she was looking at closer to 30 percent.

first published: May 29, 2015 07:18 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347